CRST: The Podcast

• Use Your Dream Team to Execute Your Keratoconus Strategy

  In this episode, experts in administrative support join Brandon D. Ayres, MD, to discuss their role in facilitating patient treatment for keratoconus. Susan DeGroot, MBA, executive director at Vance Thompson Vision, and Vivian Cole, BA, director of administrative services at Horizon Eye Specialists, explain their approaches to bringing patients into their practices, securing approval for crosslinking treatment, coordinating with referring doctors, and more. Test Your Knowledge HERE

  --------  

  22:12

  --------

  22:12
• Highlights From AECOS Europe 2025

  This special edition of CRST: The Podcast, recorded live at AECOS Europe 2025 in London, features six discussions from Eyetube’s Meeting Coverage. Topics include patient selection and long-term outcomes in presbyopia correction, advances in keratorefractive lenticule extraction, innovation in IOL customization, automated slit lamp imaging integration, solid-state laser technology, adjustable lens use in complex cases, and keratopigmentation techniques.

  --------  

  38:52

  --------

  38:52
• Refractive Innovation in Private Practice

  Neda Shamie, MD, sits down with George O. Waring IV, MD, FACS, for a conversation about his journey from academic medicine to founding the Waring Vision Institute in Charleston, South Carolina. They explore his philosophy toward refractive care, the origin and impact of the term dysfunctional lens syndrome, and how his practice uniquely blends research, surgical innovation, and patient-centered care.

  --------  

  31:13

  --------

  31:13
• Exploring the Launch of LACRIFILL® Canalicular Gel

  Jai Parekh, MD, MBA, FAAO, chief commercial officer for Nordic Pharma Inc., and Phil Gioia, president of Nordic Pharma Inc., invite Darrell White, MD, to share his real-world experiences with LACRIFILL® Canalicular Gel.

  --------  

  16:16

  --------

  16:16
• One-Year Clinical and Real-World Outcomes with the TENEO Excimer

  In this episode, Drs. Waring and Chu share clinical insights and real-world experience from the first year of using the Teneo 317 excimer laser for correcting myopia and myopic astigmatism. As the first excimer platform to receive FDA approval in over 15 years, the Teneo 317 introduces modern performance to U.S. practices with its compact design, fast ablation speed, and intuitive user interface. The conversation covers key findings from the FDA clinical trial and early post-market use, including exceptional visual acuity outcomes, improved night vision, and high levels of patient satisfaction. Sponsored by Bausch + Lomb©2025 Bausch + Lomb  TEN.0014.USA.25

  --------  

  37:31

  --------

  37:31

More Science podcasts

Trending Science podcasts

About CRST: The Podcast